Jun 10, 2022 / 04:45PM GMT
Maury Raycroft - Jefferies, LLC - Analyst
Hi everyone, my name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies, and I'm happy to introduce our guest today, Bill Lundberg, the CEO of Merus. Thanks so much for joining us today, Bill.
Bill Lundberg - Merus N.V. - President, CEO & Principal Financial Officer, Executive Director
Thanks, Maury. Appreciate your support, appreciate the support from the entire team.
Questions and Answers:
Maury Raycroft - Jefferies, LLC - AnalystAnd we're going to do a fireside chat today. So maybe to start off, for those who are new to the story, if you can give a one-minute intro highlighting your main products and key catalyst [act].
Bill Lundberg - Merus N.V. - President, CEO & Principal Financial Officer, Executive Director
Merus is a Dutch company, originally focused on making bispecific and multi-specific antibodies for cancer therapy. Our technology is based on a common light chain platform, and that gives